Vismodegib Therapy for Basal Cell Carcinoma in an 8‐Year‐Old Chinese Boy with Xeroderma Pigmentosum

作者：Douglas Fife M D; Marko A Laitinen B S; David J Myers M D; Pamela B Landsteiner M D

来源：Pediatric Dermatology, 2017, 34(2): 163-165.

DOI：10.1111/pde.13080

Abstract(#br)Vismodegib is an oral inhibitor of the Hedgehog signaling pathway and has been used to treat basal cell carcinoma ( BCC ) in adults. This article reports clearance of a nodular BCC of the nasal tip in an 8‐year‐old boy with xeroderma pigmentosum ( XP ). BCC can pose therapeutic challeng...

• 单位
  The University of Nevada